The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 12, 2018

Filed:

Jan. 31, 2014
Applicants:

Portland State University, Portland, OR (US);

Providence Health & Services—oregon, Portland, OR (US);

Inventors:

Kenneth M. Stedman, Portland, OR (US);

James R. Laidler, Portland, OR (US);

Keith Bahjat, Portland, OR (US);

Assignees:

Portland State University, Portland, OR (US);

Providence Health & Services—Oregon, Portland, OR (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); C12N 7/00 (2006.01); A61K 39/125 (2006.01); A61K 39/13 (2006.01); A61K 39/145 (2006.01); A61K 39/15 (2006.01); A61K 39/21 (2006.01); A61K 39/215 (2006.01); A61K 39/235 (2006.01); A61K 39/285 (2006.01); A61K 39/29 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); A61K 39/125 (2013.01); A61K 39/13 (2013.01); A61K 39/145 (2013.01); A61K 39/15 (2013.01); A61K 39/21 (2013.01); A61K 39/215 (2013.01); A61K 39/235 (2013.01); A61K 39/285 (2013.01); A61K 39/29 (2013.01); A61K 39/292 (2013.01); C12N 7/00 (2013.01); A61K 2039/525 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/55588 (2013.01); C12N 2710/10021 (2013.01); C12N 2710/10034 (2013.01); C12N 2710/24121 (2013.01); C12N 2710/24134 (2013.01); C12N 2720/12321 (2013.01); C12N 2720/12334 (2013.01); C12N 2740/16021 (2013.01); C12N 2740/16034 (2013.01); C12N 2760/16021 (2013.01); C12N 2760/16034 (2013.01); C12N 2770/20021 (2013.01); C12N 2770/20034 (2013.01); C12N 2770/24021 (2013.01); C12N 2770/24034 (2013.01); C12N 2770/24221 (2013.01); C12N 2770/24234 (2013.01); C12N 2770/32421 (2013.01); C12N 2770/32434 (2013.01); C12N 2770/32621 (2013.01); C12N 2770/32634 (2013.01); C12N 2795/10134 (2013.01); C12N 2795/14034 (2013.01);
Abstract

It is disclosed herein that viruses coated in silica retain infectivity and the capacity to induce an immune response in an infected host. In addition, silicified virus is remarkably resistant to desiccation. Provided herein are methods of inducing a virus-specific immune response in a subject by administering to the subject an effective amount of silicified virus or silicified virus particles. Methods of enhancing a virus-specific cell-mediated immune response (such as a T cell-mediated immune response) in a subject by administering to the subject a silicified virus or silicified virus particles are also described herein. Further provided are immunogenic compositions comprising silicified virus or silicified virus particles, such as compositions useful as vaccines. The immunogenic compositions include a pharmaceutically acceptable carrier and/or an adjuvant.


Find Patent Forward Citations

Loading…